Karen Torrejon
Fondatore presso Glauconix Biosciences, Inc.
Profilo
Karen Torrejon is the founder of Glauconix Biosciences, Inc., which was founded in 2014.
She held the title of Chief Scientific Officer from 2019 to present.
Currently, Dr. Torrejon is the Director at Capitalize Albany Corp.
Posizioni attive di Karen Torrejon
| Società | Posizione | Inizio |
|---|---|---|
Capitalize Albany Corp.
 Capitalize Albany Corp. Financial ConglomeratesFinance Capitalize Albany Corp. provides urban and rural planning services. The firm activities include loan repayments and recapitalization, real estate and project development revenues, fees for services, grant proceeds, and membership dues. The company was founded in 1979 and is headquartered in Albany, NY. | Direttore/Membro del Consiglio | - |
Glauconix Biosciences, Inc.
 Glauconix Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Glauconix Biosciences, Inc. is a company that specializes in developing ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery. The company is based in Albany, NY. The company's 3D tissue models can de-risk ophthalmic assets and expedite drug development, adding value to their clients and partners by expediting early identification and validation of effective compounds or biologics in the preclinical phase and those entering clinical trials. The company was founded in 2014 by Karen Torrejon, Feryan Ahmed. Kimberly R. Southern has been the CEO of the company since 2019. | Fondatore | 01/01/2014 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Capitalize Albany Corp.
Capitalize Albany Corp. Financial ConglomeratesFinance Capitalize Albany Corp. provides urban and rural planning services. The firm activities include loan repayments and recapitalization, real estate and project development revenues, fees for services, grant proceeds, and membership dues. The company was founded in 1979 and is headquartered in Albany, NY. | Finance |
Glauconix Biosciences, Inc.
Glauconix Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Glauconix Biosciences, Inc. is a company that specializes in developing ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery. The company is based in Albany, NY. The company's 3D tissue models can de-risk ophthalmic assets and expedite drug development, adding value to their clients and partners by expediting early identification and validation of effective compounds or biologics in the preclinical phase and those entering clinical trials. The company was founded in 2014 by Karen Torrejon, Feryan Ahmed. Kimberly R. Southern has been the CEO of the company since 2019. | Commercial Services |
- Borsa valori
- Insiders
- Karen Torrejon
